Gastrointestinal nematodes (GINs) in beef calves in the preweaning period can be an underestimated problem, and an adequate control program can result in increased productivity. In the current scenario of anthelmintic resistance, clinical studies with highly effective molecules with a prolonged period of action can contribute to the development of technologies applied in the field. The objective of this study was to evaluate the effects of a 10% moxidectin formulation (10%MOX), administered to calves aged 4–5 months, in the control of gastrointestinal nematodes and weight gain until the time of weaning. The study was divided into 2 stages. The first stage was carried out on a farm, with a randomized block design based on fecal egg counts (FEC), live weight, number of calvings of the mother, breed of the calves, and pickets. In the second stage, the study was repeated on 10 other farms, following a completely randomized design, to confirm the results obtained in the first stage. In all experiments there was a treated group and a placebo group. In the first stage, the effectiveness of 10%MOX in the FECRT performed on the 38th day post-treatment was 98.49%, and the treated animals still had lower FEC averages and a 9.4 kg increase in weight at weaning compared to those from the placebo group. In the second stage, the average increase in weight gain was 6.1 kg, confirming the results of the first stage. The study demonstrated effective control of GINs and improvement in the productive performance of calves treated in the preweaning phase, using 10% moxidectin.
The economic viability of a commercial oral anthelmintic suspension containing 10% fenbendazole was evaluated in Angus x Nelore cattle in a feedlot. Two groups of 37 animals (treated and non-treated) were formed. A random-block design was used based on initial weight, egg count per gram of feces (EPG) and carcass grade. EPG counts and the determination of weight were performed on Days 0, 42 and 122. Carcass grade and yield were determined on the day of slaughter. Economic viability was evaluated using cost-effectiveness, sensitivity and financial analyses, considering three economic scenarios: most likely (M), optimistic (O) and pessimistic (P). The anthelmintic achieved 99.89% efficacy regarding EPG reduction. The animals exhibited an increase of 20.7 kg in live weight, 20.2 kg in live weight gain and 0.166 kg in daily weight gain (p < 0.05). No effects were found on yield or carcass grade (p > 0.05). The genus Haemonchus predominated at the onset of the study, whereas only the genus Cooperia was found after treatment. A net return of 14.60 USD per animal was found in the treated group, which remained viable under O, M and P scenarios, with respective differences of 18.92%, 12.86% and 91.15% in gross profit. The treatment was financially superior under all scenarios (real, M, O and P), with reductions of 1.89, 1.04, 0.48 and 16.39 years for the recovery of the initial investment. These results demonstrate the importance of economic analysis methods in the evaluation and selection of anthelmintics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.